Short description
CellPoint Diagnostics is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer.
Description
CellPoint Diagnostics is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer. Their novel, proprietary technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.
Their goal is to commercialize products that will provide safe, non-invasive "blood-based biopsies" which will present physicians and patients with highly accurate, real-time, individualized clinical information on disease status and treatment response. They intend to identify, diagnose and guide treatment to the specific agents of lethal metastatic cancer. This has the potential to transform cancer from a deadly disease to a chronic, managed condition and will provide a powerful tool for the development of new cancer drugs.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
La Jolla, California, United States, North America
Founded on
January 1, 2006
Exited on
August 31, 2008
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Uh Ohhhh, Blurry Noaccess
Sign in for full access